Connect with us

Advocacy

“Glimmer of hope” for funding of children’s medical cannabis prescriptions

Those on the frontline say they feel optimistic about a short-term solution being reached.

Published

on

end our pain fight for children's prescriptions
Campaigners gathered in London on Tuesday 2 November

Those on the frontline say they feel optimistic about the actioning of a short-term solution to help fund children’s private prescriptions.

For the first time there is a “glimmer of hope”, say campaigners, that those in Westminster are listening to the calls of families fighting for fair access to medical cannabis.

Campaigners gathered in London on Tuesday 2 November to ask the Health Secretary Sajid Javid to “urgently intervene” to help families fund children’s medicine.

Three years since the landmark law change on 1 November 2018, only three prescriptions have been issued on the NHS.

As a result families are forced to fundraise and even sell their homes to cover the costs of private prescriptions, up to £2,000 a month.

Parents presented a petition to Downing Street calling for an emergency compassionate fund for patients which would ease the burden on families, while a more permanent solution is reached.

This would allow time for the gathering of evidence needed to allow for medical cannabis to be more widely available on the NHS.

Now MPs and long-standing supporters of the families, say they believe the Health Secretary is listening and hope that a short-term solution could be announced in the near future.

Tonia Antoniazzi, Labour MP for Gower and co-chair of the All-Party Parliamentary Group for Access to Medical Cannabis Under Prescription, told Cannabis Health she feels they could see a result following two debates in the House of Commons this week.

“Three years ago the law changed and Sajid Javid made it possible for children with intractable epilepsy to have prescriptions, unfortunately it has only resulted in three being made available by the NHS,” she said.

“We thought the fight was over, but it isn’t and we’re still battling. Now Javid is the secretary of state for health, I hope he’s listening and I think he is. I feel very positive about it and I’m hoping that after the two debates this week we will have a result and hopefully in the short term we can have the prescriptions which are currently out there, funded by the NHS.”

Ms Antoniazzi’s co-chair, Tory MP, Alberto Costa led a debate in Parliament on Wednesday highlighting the issues accessing life-changing medical cannabis prescriptions. 

A second, led by Ronnie Cowan of the Scottish National Party, will take place on Thursday 4 November. 

end our pain fight for children's prescriptions

Life-changing medicine

Parents, who have been fighting tirelessly for NHS access to what has been “life-changing” medication for their children, feel let down by a catalogue of failures in government policy.

“We’re asking Sajid Javid to urgently intervene to set up a compassionate fund, or or do anything in his power to help all of us and our children,” said Joanne Griffiths, mother of Ben, 11. 

“Every single child has shown an individual need for this medicine. Our children are the evidence, they need a policy in place for them to be able to access this.”

Karen Gray, whose son Murray has been seizure-free for two years, has a letter written by his now retired paediatric neurologist, advising that GPs should be allowed to prescribe for Murray and other children in his position.

“We’re here to ask Sajid Javiid to intervene, based on our clinician’s decision and the letter that she wrote to him to say that our GP should be prescribing,” said Karen.

“Murray spent 240 days in status in hospital, no NHS medication was helping him. He’s now been seizure free on medical cannabis for two years, he’s absolutely thriving.”

Emily Howis, joining the families for the first time on Tuesday, told us that cannabis has drastically reduced the number of seizures her two-year-old daughter, Clover, has.

“She was diagnosed with a very rare genetic disorder when she was three months old and severe intractable epilepsy is one major part of that. She got to the point where she was having 50 to 100 seizures a week,” said Emily.

“Once we started Bedrolite her seizures went down to five to six a week and since adding another oil with more THC in it, she’s down to one every six to nine days. 

Emily added: “She is doing fantastically well, cannabis has been life-changing for her, she’s doing all the things that a normal two and a half year old does.”

Nineteen-year-old Bailey Williams, is now able to lead a more independent life, something his mum, Rachel Rankmore, had never imagined would be possible.

“Bailey goes out to the community now with his carers, he’s enjoying days out to cafes, riding his adapted bike and he’ll be going to a bungalow fully adapted for him in the spring,” Rachel said.

“He’s saying he wants his own home and doesn’t want his mum and dad around anymore.”

She added: “It’s given him his life back. We never in our wildest dreams even thought about Bailey’s future like that, we just assumed that he was always going to be with us.”

end our pain fight for children's prescriptions

A glimmer of hope

Over the last three years, patients have faced a series of obstacles to accessing prescriptions, including the failure of an initially encouraging internal NHS review published in August 2019.

Despite a clarification from NICE earlier this year that there is no recommendation against the use of whole plant extract medical cannabis products in appropriate cases of paediatric epilepsy, theGovernment has yet to provide a solution for these families.

Campaigners are now cautiously optimistic that things could change.

Peter Carroll, chair of End Our Pain, the lobby group which represents the families, said he felt the events this week had been a “great success” and he was “hopeful” that they would see some action soon.

He told Cannabis Health: “My feeling from the grapevine in Westminster and Whitehall, is that the cumulative build up of pressure is actually getting through and whilst I wouldn’t over emphasise it, I do for the first time feel a slightly stronger glimmer of hope that people are listening and I’m hopeful that we’ll get at least some sort of action soon.

“This is a long, hard road. It’s emotionally draining for the people concerned, in this case, the families. I know that it’s sometimes easy to read too much into things but for the first time, I think it feels slightly more optimistic than usual, that people are listening.”

READ MORE  'Mining' the plant: The cannabis breeders on a mission to advance future medicine

Advocacy

US Congresswoman speaks out about how cannabis helped her depression

Nancy Mace spoke out about using cannabis to help her depression after experiencing a traumatic event as a teenager

Published

on

Image credit: Nancy Mace/Instagram

A Republican congresswoman who has proposed a federal bill to legalise cannabis has spoken out about her experience using cannabis to combat depression.

Nancy Mace, a republican politician from South Carolina appeared on Fox Business’s ‘Kennedy’ show to talk about the bill which would legalise cannabis but would also focus on veteran access.

It also includes expungement for non-violent cannabis crimes and imposes a revenue tax that would support reinvestment into communities hurt by the war on drugs.

Bill: A banner for always pure organics

The bill titled the States Reform Act would federally legalise and tax cannabis has been proposed ahead of competing Democrat proposed bills. While the bill was originally proposed in July, Mace shared her story after officially filing the State Reform Act in November.

At the end of the discussion, host, Lisa “Kennedy” Montgomery asked the congresswoman if she smoked cannabis.

Nancy replied: “When I was 16, I was raped. I was given prescription medication that made the feelings I had of depression worsen, and I stopped taking those prescription drugs and I turned to cannabis for a brief period of time in my life.”

She added that she believed her experience with cannabis made her more sympathetic to veterans who may use cannabis for conditions such as post-traumatic stress disorder (PTSD).

Bill protection for veterans

The congresswoman explained that the new bill is “particularity protective of veterans, ensuring they are protected, not discriminated against and that the US Department of Veteran Affairs can utilise cannabis for their PTSD.”

READ MORE  Could cannabis be legal for Londoners?

She added: “When I talk to vets and I see that pain, it hurts because I felt that pain before in my life. Veteran suicide, we see every single day.”

One other provision in the bill is that cannabis would be under the Treasury Department’s Alcohol and Tobacco Tax and Trade Bureau (TTB) instead of the Food and Drug Administration (FDA). The FDA would have some involvement similar to its current control over the alcohol industry.

Bill history

Mace has already won an exception for rape and incest victims in a fatal fetal heartbeat bill. She mentioned her history when it came to proposing that bill in 2019.

She said: “I’ve had family that have overdosed from hardcore opiates and prescription drugs. And I’ve mentioned part of this in 2019, at the time I got the exception for rape and incest in the fetal-heartbeat bill I told my story about being raped when I was 16, but I’ve never said this part publicly before: I was prescribed antidepressants afterwards, and it made my feelings a lot worse. And so I started using cannabis for a brief moment, for a time in my life. It helped me. It cut down on my anxiety and helped me get through some dark periods.”

 

Fibromyalgia: A banner advert for cannabis health news

Continue Reading

Advocacy

First patient set to receive cannabis products on Ireland’s MCAP programme

CannEpil is the first drug available through the programme but has yet to be prescribed

Published

on

Ireland HSE offer medical cannabis
CannEpil was announced as the first drug to be made available through the programme

Earlier this year, the Irish Health Service Executive (HSE) has announced that the first cannabis-based products will be available through the Medical Cannabis Access Programme from mid-October.

Despite an update from the Irish health service (HSE) and Health Products Regulatory Authority (HPRA) that CannEpil would be prescribed by the middle of October, the first prescription has been delayed.

People before Profit TD for Dublin Mid-West Gino Kenny tweeted that the first prescription should be available from next week.

The HSE has yet to confirm that the products will be available from next week but says they would not be aware until the consultant neurologist has issued claims at the end of the month.

In a statement to Cannabis Health News, a press officer at the HSE stated: “The HSE has registered three patients under the MCAP in recent days. We would not be aware whether the consultant neurologist has proceeded with prescribing for an individual until claims were submitted from pharmacies at the end of the month.”

He also raised the issue in the Dáil earlier this month to Taoiseach, Michael Martin.

“Many families would have been very joyous during the summer when the medical cannabis access programme was to commence. But sadly, in a PQ response today, not one patient has been given access thus far. That is a huge disappointment to those families that this treatment could make life-changing benefits,” he said.

READ MORE  One third of fibromyalgia patients use CBD - study

“So what do you say to families that feel let down by the program and now they have to look at other treatments and probably getting no treatment at all?” He asked.

Michael Martin replied that a lot of patients have been facilitated by the original ‘imported license’ but he was unsure as to why patients had not availed of the MCAP. He promised to follow up with the Minister for Health, Stephen Donnelly of Fianna Fáil.

Gino announced changes to the Cannabis Regulation and Control bill that he is due to submit. It will now take place next year with a focus on production and consumption for personal use.

HSE committee meeting

In a joint committee meeting held in September, CannEpil was announced as the first drug to be made available through the program from mid-October.

Ireland’s Health minister Stephen Donnelly announced funding for the Medical Cannabis Access Programme (MCAP) in January, almost two years since the legislation was signed off in June 2019.

The programme will offer access to cannabis-based medicines to people living with one of three qualifying conditions. These include intractable nausea and vomiting associated with chemotherapy, severe treatment-resistant epilepsy and spasticity associated with multiple sclerosis (MS) where patients have failed to respond to authorised treatments.

The meeting saw officials from the Department of Health and the Health Products Regulatory Authority (HPRA) outline the current state of the MCAP programme and the Ministerial License system.

READ MORE  "BPNA rules deny safe treatment for children"– clinicians write open letter to Sajid Javid

The suppliers of two products, CannEpil and Tilray are said to have confirmed their prices to the HSE, but Tilray has yet to announce its availability date.  Two more cannabis-based products have been added to the schedule but suppliers are not thought to have current plans to supply the Irish market.

Morris O’Connor, the assistant national director of primary care reimbursement, announced that two additional products were expected to be added to the schedule in the coming weeks and that the programme may be extended for longer than the initial five year pilot period.

He stated: “There are currently four cannabis products on the schedule and two more to be added to schedule one of the regulations in the coming weeks. I understand that one of the products in the schedule namely CannEpil is expected to be available in October, subsequent to the introduction of the necessary legislation.”

According to Lorraine Nolan the chief executive of HPRA, since the MCAP regulations came into force in June 2019, 34 applications have been made for cannabis-based products.

Of these four cannabis oils have been placed in schedule one of the regulations, and two dry herb products have completed the final HPRA review and are awaiting a ministerial decision. Five are currently under active review.

Nolan commented: “The first cannabis-based products are expected to be made available to Irish patients through MCAP in October 2021. Once these are accessed by Irish patients, the HPRA will receive any reports of suspected adverse events and review them for any signals of concern regarding the safety of the product.

READ MORE  Three years on: Why we're still fighting for fair access to medical cannabis

“The HPRA will also have a role in investigating any quality issues that may arise and coordinate any action that might be subsequently required.”

Doctors are asked to register patients who may benefit from this treatment to the HSE including the condition they are being prescribed for.

The HPRA will be monitoring patients for adverse effects over the coming weeks once the medication is available.

The MCAP programme has been criticised by patients who are still waiting for access to products despite the introduction of the scheme in 2019 under then Minister for Health, Simon Harris.

O’Conner also highlighted that 192 ministerial licenses have already been issued for 67 individuals who access medication from the Netherlands.

In July a direct funding scheme was announced to remove the need for patients to pay for these prescriptions up front and then apply for reimbursement from the Government.

Continue Reading

Advocacy

Irish politicians receive cannabis in mail to mark National Legalise Cannabis day

The letters outlined the reasons why legalising cannabis in Ireland needs to be a top priority for government officials.

Published

on

Irish: A banner advert for National Legalise cannabis day

Two hundred Irish TDs received a letter outlining the reasons for cannabis legalisation and a roll-up in the post sparking an investigation

The cannabis was sent by An Póst by leading cannabis activists to mark National Legalise Cannabis Day in Ireland. The cannabis was accompanied by a letter outlining ten reasons why cannabis should be legalised and made accessible. Cannabis activists including Cannabis Activist Alliance, ReLeaf CBD Café, and Martin Condon from the podcast Martin’s World shared images of the letters online before sending them to ministers.

Two hundred letters containing cannabis roll-ups and edibles were sent to ministers including the President of Ireland, Michael D Higgins. A further forty were sent to members of the media and senators. Mary Lou McDonald of Sinn Fein was even sent a tricolour roll-up.

In a statement online, those involved encouraged other cannabis consumers and activists to get involved in the action.

“To mark the 20th anniversary of this event the Martins World Podcast, The Cannabis Activist Alliance and the ReLeaf Cafe have teamed up to recreate this event. Cannabis containing joints will again be posted to every TD and Senator in Ireland. With the joint, we will include a letter about the campaign and 10 reasons why Cannabis prohibition should be ended (there are thousands to choose from). We encourage anyone who wants to get involved to do so. It will only cost you the price of a stamp and envelope.”

Some of the benefits listed in the letters included the creation of jobs, open access for patients and researchers, the end to the discrimination faced by patients and also the protection of minors with the introduction of regulation.

READ MORE  Spinal cord injury and cannabis: Why patients are turning to complementary therapies

Irish cannabis market

While the letter highlighted the reasons why cannabis should be legalised in Ireland, it also gave a stern warning about the dangers of buying cannabis from an unregulated market.

“As this product was sourced from an unregulated market, you as a consumer have very little protection. There is no guarantee that this joint contains any cannabis. If it does contain cannabis you as a consumer have no idea as to the potency of the cannabis. This makes dosing incredibly difficult and could put you at risk.”

The action has sparked an investigation by Irish authorities after scanners at the ministerial buildings failed to recognise the substance. It was reported that nearly all of the Green party received a letter along with members of Fianna Fáil and Fine Gael.

Irish ministers response

Most of the ministers have not confirmed if they have or have not received the letters. However, Cathal Crowe, a Fianna Fáil TD for Clare posted a photo of the letter on Twitter confirming he had received one.

Irish Green party councillor, Oliver Moran also received a letter and tweeted his response. “Many thanks for including me in this action—and for the prudent warning that potency and content are unknown when drugs are purchased from an underground market.”

November 5 was declared  National Legalise Cannabis Day by Independent TD, Luke Ming Flanagan back in 2001. The letters campaign was created to mark the 20th anniversary of this.

READ MORE  Three years on: Why we're still fighting for fair access to medical cannabis

Ireland’s cannabis reform

The campaign comes amidst criticism that the Medical Cannabis Access Programme is still not functioning despite reassurances that Cannephil would be available from mid-October.

People before Profit TD for Dublin Mid-West, Gino Kenny raised the issue in the Dáil to Taoiseach, Michael Martin.

“Many families would have been very joyous during the summer when the medical cannabis access programme was to commence. But sadly, in a PQ response today, not one patient has been given access thus far. That is a huge disappointment to those families that this treatment could make life-changing benefits,” he said.

He added: “So what do you say to families that feel let down by the program and now they have to look at other treatments and probably getting no treatment at all?”

Michael Martin replied by saying that a lot of patients have been facilitated by the original ‘imported license’ but was unsure as to why patients had not availed of the MCAP. He promised to follow up with the Minister for Health which is currently Stephen Donnelly of Fianna Fáil.

Gino also announced changes to the Cannabis Regulation and Control bill that he is due to submit. It will now take place next year with a focus on production and consumption for personal use.

Image credit : Martin’sWorld

READ MORE  'Mining' the plant: The cannabis breeders on a mission to advance future medicine

Irish: A banner advertising a competition

Continue Reading

Trending